The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung

Clinical and Experimental Allergy

Volumn 29, Issue 3, 1999, Pages 314-322

  Lampinen, M ^a   Rak, S ^b   Venge, P ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asthma; BAL; Chemotaxis; Cytokines; Eosinophils

Indexed keywords

CYTOKINE; NEUTRALIZING ANTIBODY; RANTES; RECOMBINANT INTERLEUKIN 5; RECOMBINANT INTERLEUKIN 8; RECOMBINANT PROTEIN;

ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; BLOOD DONOR; BRONCHUS HYPERREACTIVITY; CHEMOTAXIS; CLINICAL ARTICLE; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; LUNG LAVAGE; MALE; PRIORITY JOURNAL;

ADULT; ASTHMA; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-5; INTERLEUKIN-8; LUNG; MALE; RANTES;

EID: 0033007230     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00390.x     Document Type: Article

References (34)

1. 1 Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991; 87:893-910.
2. 2 Gleich GJ. The eosinophil and bronchial asthma: Current understanding. J Allergy Clin Immunol 1990; 85:422-36.
3. 3 Venge P, Håkansson L. The eosinophil and asthma. In: Kaliner, Persson, Barnes, Debber M, eds Asthma: Pathophysiology and Treatment. 1990.
4. 4 Rak S. Björnson A, Håkansson L, Sörenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991; 88:878-88.
5. 5 Venge P, Håkansson L. Current understanding of the role of the eosinophil granulocyte in asthma. Clin Exp Allergy 1991; 21:31-7.
6. 6 Walker C, Virchow J-C, Bruijnzeel PLB, Blaser K. T cell subssets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991; 146: 1829-35.
7. 7 Ackerman V, Marini M, Vittori E et al. Detection of Cytokines and Their Cell Sources in Bronchial Biopsy Specimens from Asthmatic Patients. Chest 1994; 105:687-96.
8. 8 Garcia-Zepeda EA, Rothenberg ME, Ownbey RT et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996; 2:449-56.
9. 9 Jose PJ, Griffiths-Johnson DA, Collins PD et al. Eotaxin: A Potent Eosinophil Chemoattractant Cytokine Detected in a Guinea Pig Model of Allergic Airways inflammation. J Exp Med 1994; 179:881-7.
10. 10 Ponath PD, Qin S, Ringler DJ et al. Cloning of the human eosinophil chemoattractant, eotaxin. J Clin Invest 1996; 97:604-12.
11. 11 Venge J, Lampinen M, Håkansson L, Rak S, Venge P. Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol 1996; 97:1110-5.
12. 12 Rand TH, Silberstein DS, Kornfeld H, Weller PF. Human eosinophils express functional interleukin 2 receptors. J Clin Invest 1991; 88:825-32.
13. 13 Sehmi R, Cromwell O, Wardlaw AJ, Moqbel R, Kay AB. Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy 1993; 23:1027-36.
14. 14 Warringa RAJ, Mengelers HJJ, Raaijmakers JAM, Bruijnzeel PLB, Koenderman L. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 1993; 91:1198-205.
15. 15 Håkansson L, Venge P. The influence of serum on random migration and chemotaxis of polymorphonuclear leucocytes: Methodological evaluation using sera from infection-prone patients and normals. Scand J Immunol 1980; 11:271-82.
16. 16 Hansel TT, De Vries IJM, Iff T et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991; 145:105-10.
17. 17 Håkansson L, Venge P. Priming of eosinophil and neutrophil migratory responses by interleukin-3 and interleukin-5. APMIS 1994; 102:1-7.
18. 18 Falk W, Goodwin RH, Jr Leonard EJ. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 1980; 33:239-47.
19. 19 Wilkinson PC. Principles of the measurement of leukocyte chemo-taxis using Boyden's method. In: AnonymousChemotaxis and inflammation. London: Churchill Livingston, 1974:33-53.
20. 20 Håkansson L, Westerlund D, Venge P. New method for the measurement of eosinophil migration. J Leukocyte Biol 1987; 42:689-96.
21. 21 Wang JW, Rambaldi A, Biondi A et al. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol 1989; 19:701-5.
22. 22 Alam R, Stafford S, Forsythe P et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993; 150:3442-7.
23. 23 Kameyoshi Y, Schröder J-M, Christophers E, Yamamoto S. Identification of the cytokine RANTES released from platelets as an eosinophil chemotactic factor. Int Arch Allergy Immunol 1994; 104(Suppl. 1):49-51.
24. 24 Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines III. Effect chemokine RANTES. J Immunol 1994; 153:2153-60.
25. 25 Schweizer RC, Welmers BAC, Raaijmakers JAM et al. RANTES-and Interleukin-8-Induced Responses in Normal Human Eosinophils: Effects of Priming With Interleukin-5. Blood 1994; 83:3697-704.
26. 26 Heath H, Qin S, Rao P et al. Chemokine receptor usage by human eosinophils. J Clin Invest 1997; 99:178-84.
27. 27 Sehmi R, Wardlaw AJ, Cromwell O et al. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 1992; 79:2952-9.
28. 28 Teran L, Noso N, Carroll M et al. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol 1996; 157:1806-12.
29. 29 Lamkhioued B, Renzi PM, Abi-younes S et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997; 159:4593-601.
30. 30 Dahinden CA, Geiser T, Brunner T et al. Monocyte Chemotactic Protein 3 Is a most Effective Basophil-and Eosinophil-activating Chemokine. J Exp Med 1994; 179:751-6.
31. 31 Garcia-Zepeda EA, Combadiere C, Rothenberg ME et al. Human monocyte chemoattractant protein (MCP) -4 is a novel CC chemokine with activities on monocytes, eosinophils and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR) -2 and -3. J Immunol 1996; 157:5613-26.
32. 32 Anderson GP, Coyle AJ. Th2 and Th2-like cells in allergy and asthma: pharmacological perspectives. TiPS 1994; 15:324-33.
33. 33 Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988; 137:62-9.
34. 34 Miyamasu M, Hirai K, Takahashi Y et al. Chemotactic agonists induce cytokine generation in eosinophils. J Immunol 1995; 154:1339-49.